News Regulated Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC EN NL October 23, 2025
News Regulated Oxurion Receives Amended Transparency Notifications from Atlas Special Opportunities II LLC EN NL October 17, 2025
News Regulated Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC EN NL October 16, 2025
News Regulated Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas EN NL October 15, 2025
Inside information News Regulated Oxurion signs letter of intent for the contemplated acquisition of a CRO with strong complementarity to Axiodis EN NL FR October 13, 2025
Inside information News Regulated Oxurion provides an update related to its investment strategy in digital assets EN NL FR October 9, 2025
News Regulated Transparency/Denominator Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas EN NL October 3, 2025
News Regulated Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC EN NL October 2, 2025
General Inside information News Regulated Axiodis CRO, the French subsidiary of the Oxurion Group, announces a dual AI-driven strategic initiative to transform clinical trials EN NL FR September 16, 2025
News Regulated Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC EN NL September 8, 2025
News Regulated Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC EN NL September 1, 2025
Inside information News Regulated Oxurion confirms progress in negotiations related to its treasury diversification strategy; closing of the transaction expected before September 25, 2025 EN NL FR September 1, 2025
Inside information News Regulated Oxurion Ends R&D Program in Geographic Atrophy and Refocuses on New CRO Activities EN NL FR August 7, 2025
News Regulated Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC EN NL August 6, 2025
Inside information News Regulated Oxurion announces it obtained an improved indicative €30 million financing offer to initiate its plan to diversify by allocating part of its treasury into digital assets EN NL FR August 4, 2025
General Inside information News Regulated Oxurion completes the acquisition of Axiodis CRO and accelerates the structuring of its European clinical data platform EN NL FR August 4, 2025
News Regulated Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC EN NL July 30, 2025
News Regulated Transparency/Denominator Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas EN NL July 30, 2025
